UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 130

Sortiert nach

Persistent HIV‐controllers are more prone to spontaneously clear HCV: a retrospective cohort study

Journal of the International AIDS Society, 2020-09, Vol.23 (9), p.e25607-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Mesenchymal stromal cells in human immunodeficiency virus‐infected patients with discordant immune response: Early results of a phase I/II clinical trial

Stem cells translational medicine, 2021-04, Vol.10 (4), p.534-541

2021

Link zum Volltext

Verfügbarkeit prüfen

Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

Clinical and translational medicine, 2022-01, Vol.12 (1), p.e704-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Differential miRNA plasma profiles associated with the spontaneous loss of HIV‐1 control: miR‐199a‐3p and its potential role as a biomarker for quick screening of elite controllers

Clinical and translational medicine, 2021-07, Vol.11 (7), p.e474-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure

Scientific reports, 2020-02, Vol.10 (1), p.1902-1902, Article 1902

2020

Link zum Volltext

Verfügbarkeit prüfen

Inositol pyrophosphate mediated pyrophosphorylation of AP3B1 regulates HIV-1 Gag release

Proceedings of the National Academy of Sciences - PNAS, 2009-12, Vol.106 (50), p.21161-21166

2009

Link zum Volltext

Verfügbarkeit prüfen

HIV-1-specific T-cell responses and exhaustion profiles in people with HIV after switching to dual therapy vs. maintaining triple therapy based on integrase inhibitors

Biomedicine & pharmacotherapy, 2023-12, Vol.168, p.115750-115750, Article 115750

2023

Link zum Volltext

Verfügbarkeit prüfen

Sensitive Deep-Sequencing-Based HIV-1 Genotyping Assay To Simultaneously Determine Susceptibility to Protease, Reverse Transcriptase, Integrase, and Maturation Inhibitors, as Well as HIV-1 Coreceptor Tropism

Antimicrobial agents and chemotherapy, 2014-04, Vol.58 (4), p.2167-2185

2014

Link zum Volltext

Verfügbarkeit prüfen

Immunological history governs human stem cell memory CD4 heterogeneity via the Wnt signaling pathway

Nature communications, 2020-02, Vol.11 (1), p.821-821, Article 821

2020

Link zum Volltext

Verfügbarkeit prüfen

Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes

Frontiers in immunology, 2022-09, Vol.13, p.912579-912579

2022

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral Treatment for HIV Elite Controllers?

Pathogens & immunity, 2020, Vol.5 (1), p.121-133

2020

Link zum Volltext

Verfügbarkeit prüfen

Immunoescape of HIV-1 in Env-EL9 CD8 + T cell response restricted by HLA-B14:02 in a Non progressor who lost twenty-seven years of HIV-1 control

Retrovirology, 2022-03, Vol.19 (1), p.6-6, Article 6

2022

Link zum Volltext

Verfügbarkeit prüfen

Evolution of Serum Acute-Phase Glycoproteins Assessed by 1H-NMR in HIV Elite Controllers

Frontiers in immunology, 2021-09, Vol.12, p.730691-730691

2021

Link zum Volltext

Verfügbarkeit prüfen

Immune Correlates of Natural HIV Elite Control and Simultaneous HCV Clearance-Supercontrollers

Frontiers in immunology, 2018-12, Vol.9, p.2897-2897

2018

Link zum Volltext

Verfügbarkeit prüfen

The Other Side of SARS-CoV-2 Infection: Neurological Sequelae in Patients

Frontiers in aging neuroscience, 2021-04, Vol.13, p.632673-632673

2021

Link zum Volltext

Verfügbarkeit prüfen

Elevated α-Ketoglutaric Acid Concentrations and a Lipid-Balanced Signature Are the Key Factors in Long-Term HIV Control

Frontiers in immunology, 2022-04, Vol.13, p.822272-822272

2022

Link zum Volltext

Verfügbarkeit prüfen

Differential Gag-Specific Polyfunctional T Cell Maturation Patterns in HIV-1 Elite Controllers

Journal of Virology, 2012-04, Vol.86 (7), p.3667-3674

2012

Link zum Volltext

Verfügbarkeit prüfen

Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in aged people

JCI insight, 2022-09, Vol.7 (17)

2022

Link zum Volltext

Verfügbarkeit prüfen

CD63 Is Not Required for Production of Infectious Human Immunodeficiency Virus Type 1 in Human Macrophages

Journal of Virology, 2008-05, Vol.82 (10), p.4751-4761

2008

Link zum Volltext

Verfügbarkeit prüfen

Altered Expression of CD300a Inhibitory Receptor on CD4+ T Cells From Human Immunodeficiency Virus-1-Infected Patients: Association With Disease Progression Markers

Frontiers in immunology, 2018-07, Vol.9, p.1709-1709

2018

Link zum Volltext

Verfügbarkeit prüfen

Improved CD4 T cell profile in HIV-infected subjects on maraviroc-containing therapy is associated with better responsiveness to HBV vaccination

Journal of translational medicine, 2018-08, Vol.16 (1), p.238-238, Article 238

2018

Link zum Volltext

Verfügbarkeit prüfen

Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19

Microorganisms (Basel), 2021-10, Vol.9 (11), p.2259

2021

Link zum Volltext

Verfügbarkeit prüfen

Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controllers

BMC medicine, 2018-02, Vol.16 (1), p.30-30, Article 30

2018

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 Evolution and Spike-Specific CD4+ T-Cell Response in Persistent COVID-19 with Severe HIV Immune Suppression

Microorganisms (Basel), 2022-01, Vol.10 (1), p.143

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(121)

Publikationsform

Sprache

Englisch
(130)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Persistent HIV‐controllers are more prone to spontaneously clear HCV: a retrospective cohort study

Mesenchymal stromal cells in human immunodeficiency virus‐infected patients with discordant immune response: Early results of a phase I/II clinical trial

Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

Differential miRNA plasma profiles associated with the spontaneous loss of HIV‐1 control: miR‐199a‐3p and its potential role as a biomarker for quick screening of elite controllers

Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure

Inositol pyrophosphate mediated pyrophosphorylation of AP3B1 regulates HIV-1 Gag release

HIV-1-specific T-cell responses and exhaustion profiles in people with HIV after switching to dual therapy vs. maintaining triple therapy based on integrase inhibitors

Sensitive Deep-Sequencing-Based HIV-1 Genotyping Assay To Simultaneously Determine Susceptibility to Protease, Reverse Transcriptase, Integrase, and Maturation Inhibitors, as Well as HIV-1 Coreceptor Tropism

Immunological history governs human stem cell memory CD4 heterogeneity via the Wnt signaling pathway

Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes

Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients

Antiretroviral Treatment for HIV Elite Controllers?

Immunoescape of HIV-1 in Env-EL9 CD8 + T cell response restricted by HLA-B14:02 in a Non progressor who lost twenty-seven years of HIV-1 control

Evolution of Serum Acute-Phase Glycoproteins Assessed by 1H-NMR in HIV Elite Controllers

Immune Correlates of Natural HIV Elite Control and Simultaneous HCV Clearance-Supercontrollers

The Other Side of SARS-CoV-2 Infection: Neurological Sequelae in Patients

Elevated α-Ketoglutaric Acid Concentrations and a Lipid-Balanced Signature Are the Key Factors in Long-Term HIV Control

Differential Gag-Specific Polyfunctional T Cell Maturation Patterns in HIV-1 Elite Controllers

Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in aged people

CD63 Is Not Required for Production of Infectious Human Immunodeficiency Virus Type 1 in Human Macrophages

Altered Expression of CD300a Inhibitory Receptor on CD4+ T Cells From Human Immunodeficiency Virus-1-Infected Patients: Association With Disease Progression Markers

Improved CD4 T cell profile in HIV-infected subjects on maraviroc-containing therapy is associated with better responsiveness to HBV vaccination

Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19

Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controllers

SARS-CoV-2 Evolution and Spike-Specific CD4+ T-Cell Response in Persistent COVID-19 with Severe HIV Immune Suppression

Suchergebnisse filtern